Scinovex
articleTop 1% cited

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. FuThomas F. PajakAndy TrottiChristopher U. JonesSharon A. SpencerTheodore L. PhillipsAdam S. GardenJohn A. RidgeJay S. CooperK. Kian Ang
Head and Neck Cancer StudiesAdvanced Radiotherapy TechniquesCholangiocarcinoma and Gallbladder Cancer StudiesMedicineHyperfractionationRadiation therapyDose fractionationFractionationConcomitantNuclear medicineHead and neckHead and neck cancerUrology

MeSH terms

AdultAgedAged, 80 and overCarcinoma, Squamous CellFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedRadiation InjuriesTime FactorsTreatment FailureDisease-Free SurvivalDose Fractionation, Radiation
Citations
1,357
FWCI
83.74
field-weighted impact
References
46
Percentile
100%
vs. same field & year
Citations per year
Cited by
The EGFR as a target for anticancer therapy—focus on cetuximab
European Journal of Cancer · 2001 · 557 citations
Outcome of Salvage Total Laryngectomy Following Organ Preservation Therapy
Archives of Otolaryngology - Head and Neck Surgery · 2003 · 511 citations
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer
International Journal of Radiation Oncology*Biology*Physics · 2001 · 629 citations
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.